A basic scientist’s odyssey in nutrition by Trayhurn, Paul
17 December 2017 
 
 
 
 
PERSPECTIVE 
 
A basic scientist’s odyssey in nutrition 
 
P Trayhurn 
 
Obesity Biology Unit, University of Liverpool, Liverpool, UK and Clore Laboratory, University of Buckingham, 
Buckingham, UK  
 
 
Running title:  An odyssey in nutrition 
  
 
Correspondence should be addressed to: 
Emeritus Professor Paul Trayhurn, FRSE 
Clore Laboratory 
University of Buckingham  
Hunter Street 
Buckingham MK18 1EG 
UK 
 
Email:  p.trayhurn@liverpool.ac.uk 
Fax:  +44 1280 820 135 
 
 
 
 
  
1 
 
Many whose research career has been in nutrition have found themselves in the area both by 
accident and without formal training - and this is very much so in my case. I am a basic scientist 
motivated principally by the desire to understand physiological systems. My first degree was in 
Physiology & Biochemistry, followed by a doctorate in Biochemistry. Although my doctoral 
studies were on the metabolism of the lens under the supportive supervision of Ruth van 
Heyningen, the Nuffield Laboratory of Ophthalmology in Oxford where I studied had as its 
head Antoinette Pirie, one of whose interests was the impact of vitamin A deficiency on 
xerophthalmia. To that extent I had some early, albeit tangential, exposure to nutrition.  
My doctoral studies serendipitously brought me into contact with the legendary Nobelist, 
Sir Hans Krebs. After his retirement from the Whitley Chair of Biochemistry at Oxford, he 
established a Metabolic Research Unit in the Radcliffe Infirmary close to where my lab was 
based. Each time I returned from the local slaughterhouse with cattle eyes for my work, Sir Hans 
would personally come to collect the vitreous humour as a culture medium which I would 
transfer to him in a considerable state of awe.  
 
INTO NUTRITION 
My formal move into nutrition, which followed post-doctoral posts in Strasbourg on the retina 
and then back in Oxford on the lens, began in 1975 when I joined the Energy Group being 
established by Philip James at the MRC Dunn Nutritional Laboratory in Cambridge. The Dunn, 
with its distinguished history, was a remarkable place. It was full of highly talented scientists, 
resources appeared unlimited, and there was considerable freedom to go where the science 
demanded. Colleagues from the Dunn have remained my life-long friends, especially Prakash 
Shetty and David Fraser both of whom became god-parents to our eldest son.  
My research in Cambridge initially centred on using animal models to explore the 
energetics of obesity and we set-up colonies of ob/ob mice to represent the extreme form of the 
disorder. Detailed energy balance studies clearly demonstrated that obesity can develop in the 
absence of hyperphagia through a reduction in energy expenditure, and this quickly led to an 
interest in thermoregulation and thermogenesis.1-3 When we began to explore the biochemical 
basis of reduced thermogenesis in obesity, brown adipose tissue (BAT) was emerging as the key 
thermogenic organ through work by Foster and Frydman in Ottawa.4-5 From 1978 onwards, 
brown fat became my central interest and our group was one of the pioneers, alongside Jean 
Himms-Hagen (Ottawa) and Michael Stock and Nancy Rothwell (London), of the link between 
BAT, energy metabolism and obesity.  
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At the Dunn, my team demonstrated substantial changes in the thermogenic activity of 
BAT in a range of energetically demanding situations, including lactation, overfeeding and fasting 
- as well as in different animal obesities. Our key contributions included identifying a major 
suppression of BAT thermogenesis in lactation, which helps meet the energy costs of milk 
production.6 We also showed that brown fat is a major site of lipogenesis, particularly in mice 
acclimated to the cold where it is considerably more important than the liver7, and with my 
student Stewart Mercer we established that the development of insulin resistance severely 
compromises the thermogenic activity of BAT.8 Another student, Anne Goodbody, and I had a 
inspirational collaboration with Nancy Rothwell and Mike Stock, in which we showed that the 
diet-induced thermogenesis that they had recorded in rats overfed on a ‘cafeteria diet’, and which 
they had linked to brown fat,9 was associated with an activation of the proton conductance 
pathway in BAT mitochondria.10 This collaboration featured in a BBC Horizon television 
programme on brown fat and obesity in 1979. 
In addition to ob/ob mice, we established colonies of other obese mutants, including 
Zucker fa/fa rats and db/db mice, and also maintained both golden and Djungarian hamsters. 
This was on the August Krogh principle that "for many problems there is an animal on which it 
can be most conveniently studied". The facility to maintain multiple animal models at the Dunn 
without charge to the investigator was remarkable – as I discovered when I moved to the 
University of Alberta (Canada) in 1986 as Professor and Heritage Scholar in Nutrition & 
Metabolism and received my first billing for a colony of ob/ob mice. The move to Alberta came 
as a consequence of the recruitment being undertaken by the two major Universities in the 
Province, funded through the Alberta Heritage Foundation for Medical Research which had 
been established from the oil revenues. At that period, and as a scientist in his mid-30s, being 
offered several hundred thousand dollars to set up a new lab was irresistible. Brown fat remained 
my core interest in Alberta, and I took the opportunity to extend a comparative approach, 
including exploring thermogenesis in the tissue during the profound seasonal obesity and 
hibernation cycles of ground squirrels.11 
 By chance, oil centres have been a feature of some of my subsequent affiliations. After 
Alberta, I moved to the Rowett Research Institute in Aberdeen – the oil capital of Europe - as 
Head of the Division of Biomedical Sciences. My other oil-linked association came much later 
when in 2014 I was privileged to be appointed to a Distinguished Scientist Fellowship at King 
Saud University, Saudi Arabia, funded through the Kingdom’s oil wealth. 
 During the early years at the Rowett my focus continued to be on BAT, again with a 
comparative perspective which included studies on the tissue in the newborn of large precocial 
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species, particularly goats and reindeer. These studies explored the rapid post-natal transition of 
BAT to white fat in these animals. Working on species of agricultural importance was one of the 
multiple opportunities afforded by the Rowett. Another was the wide range of collaborative 
possibilities, one of which resulted in a serendipitous observation with John Arthur that selenium 
deficiency leads to a fall in the ability of rats to respond to cold through activation of T3 
production in BAT.12 
For some while I had been considering moving on from BAT, primarily as a 
consequence of the then prevailing view that the tissue was of little relevance to human 
energetics; this perspective has changed markedly in recent years following studies employing 
fluorodeoxyglucose positron emission tomography.13 Just before Christmas 1994 my research 
programme switched abruptly to the endocrine role of white adipose tissue (WAT) following the 
cloning of the ob gene (Lep) and the discovery of leptin.14 I vividly remember receiving the issue 
of Nature of 1 December 1994 in which this work was published, and within days my group had 
produced probes to measure the expression of the ob gene. Six months later our first paper on 
leptin was published in which Vernon Rayner and I showed that expression of the ob gene was 
nutritionally regulated, fasting leading to a marked suppression of expression which was rapidly 
reversed on refeeding.15 One of the other highlights of our leptin work was the demonstration 
that expression of the gene is strongly suppressed by activation of the sympathetic nervous 
system, this operating via β3-adrenoceptors.16-17 We also produced the first ELISA for the 
hormone.18 
The rapidity with which I moved to work on leptin has a simple explanation. Some two 
years earlier a consortium of us in the UK, which included Mike Stock, had tried to obtain 
funding to identify the defective genes in obese mutants, but were unsuccessful with reviewers 
noting that since researchers at the Rockefeller were well advanced in the same goal it was 
unlikely that we would be competitive. This view proved quite correct, and my response was that 
I would wait until the key gene(s) had been identified and then explore the physiology of the 
encoded protein(s).  
For several years, leptin was the subject of intense activity by my group. However, 
unsurprisingly many others quickly focused on such an important factor and hundreds of papers 
were soon being published on leptin each year. My philosophy has been that if an area becomes 
quasi-industrial in scale it is appropriate to move on since it is then difficult to make a 
substantive contribution. For the next decade the broader concept of adipokines beyond leptin 
became my main interest, initially in the Rowett and then subsequently at the University of 
Liverpool, punctuated by a brief sojourn at the Institute of Nutrition, University of Oslo, as part 
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of their internationalisation. Leaving Aberdeen was a wrench, and I consider myself extremely 
fortunate to have been one of the handful of scientists who have worked at two such 
internationally acclaimed nutritional research centres as the Dunn and the Rowett. I am also 
fortunate to have been in two of the world’s great academic centres – Oxford and Cambridge.  
At Liverpool, as in Alberta, I was appointed primarily for research with teaching being 
through the supervision of Master’s and Doctoral students. The central interests of our work in 
Liverpool were on the discovery of novel adipokines from human fat cells (including, with Chen 
Bing, the lipolytic factor zinc-α2-glycoprotein19 – a highly abundant protein secreted by 
adipocytes) and the inflammation that develops in WAT as it expands in obesity, this expansion 
underpinning the development of obesity-associated disorders.  
A question that greatly intrigued me was why inflammation occurs in WAT as adipocytes 
expand. In 2004 we proposed that the answer might be hypoxia, adipocytes being oxygen-
deprived as they enlarge and become distant from the vasculature, this leading to a series of 
metabolic adaptations involving the recruitment of the key hypoxia-inducible transcription 
factor, HIF-1.20-21 The studies that Stuart Wood, Bohan Wang and I conducted over the 
following few years demonstrated pervasive effects of hypoxia on human adipocytes – from 
alterations in the expression of >1300 genes to substantial changes in the production of key 
adipokines such as leptin, and major increases in glucose utilisation and disposal (Figure 1).22-23 
The ways in which variations in O2 level modulate cellular function have continued to 
fascinate me, and I have recently argued that O2 is a “forgotten macronutrient” – an overlooked 
dimension of nutrition (Figure 2).23-24 This has been a particular interest following my retirement 
from Liverpool, after which I have held ‘post-retirement’ part-time positions at the University of 
Buckingham, including as Dean of Research Strategy.  
 
PERSPECTIVES 
Science, as with other areas of academia, functions as a ‘prestige-based economy’ with the capital 
of reputation mattering more than financial rewards. I am fortunate to have received some 
recognition: my scientific work has been highly cited, I was elected to Fellowship of the Royal 
Society of Edinburgh (National Academy of Scotland) in 1997, and in 2008 received the 
Wassermann Award for lifetime contributions to obesity research from the European 
Association for the Study of Obesity. Particular satisfaction came from my role as Editor-in-
Chief of the British Journal of Nutrition, and I was delighted that during my tenure (1999-2005) the 
rate of submissions more than doubled. 
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Over a number of years I have represented nutrition in Research Councils and other 
funding bodies, as well as in Learned Societies and various Scientific Committees, both in the 
UK and internationally. But I have often seen myself as being towards the periphery of nutrition, 
and not only because of being a basic scientist who entered the field by chance. One reason is 
that my work on energy metabolism and obesity has concerned total intake/expenditure and 
adipose tissue function, rather than nutrition per se. Another is that I have remained 
uncomfortable with the evangelism that can flavour nutritional discourse in some quarters, 
especially in matters of public health. 
 This leads me to science as a social construct. When in the 1980s I first became aware of 
this concept my response was of disbelief. I held the customary view that science was 
dispassionate and objective, with the choice of problem and approach being driven entirely by 
scientific factors. However, working on obesity has emphasised that how we view a scientific 
problem is coloured by social and cultural attitudes. When I began in obesity research the core 
paradigm was ‘gluttony and sloth’, and those of us exploring metabolic parameters were running 
counter to the prevailing cultural view centred on personal choice and responsibility. However, 
over the past 40 years views on causality have switched to genetics and particularly to the 
‘obesogenic environment’. While there is undoubtedly a genetic predisposition, and the 
environment does facilitate over-consumption and encourage sedentary behaviours, this has 
been accompanied by the implication that the individual has minimal control over, or 
responsibility for, their weight. This parallels development of the presumption that solutions to 
most problems lie firmly with Governments. 
The climate in which science is conducted has changed markedly during my career, and 
this also reflects evolving societal attitudes. There is more managerialism, more pressure to 
deliver results, and Governments have become directly involved. One of the biggest changes is 
the importance now attached to the status of the journal when selecting where to publish, 
particularly the ‘impact factor’. In some countries an immediate financial reward is given for 
papers in high impact journals, which may amount to tens of thousands of dollars for a 
publication in Nature or Science. There is a real risk that such rewards will fuel scientific 
misconduct. When I started in the Dunn, while a paper in Nature was regarded as good, it was 
not career-changing in the way it is now, and what was required in terms of content was much 
less extensive.  
My first Nature paper, which was my earliest nutrition article, demonstrated that a 
thermogenic defect in ob/ob mice precedes the development of obesity, and that the impaired 
temperature regulation of pre-obese ob/ob animals provides a simple means of identifying the 
6 
 
mutants before the phenotype is manifested.1 However, the paper contained just two Figures 
with rectal temperature curves (Figure 3), together with a Table showing how successful we were 
in identifying genotype - and the sole tool employed was a rectal thermistor probe. If so little 
information was submitted today, based on such simple measurements, the rejection email would 
arrive within minutes. 
 
CONCLUDING COMMENTS 
Nutrition is an integrative science. However, it has traditionally been segmented by species – 
whether farm, companion or laboratory animals, or humans – by the level of organisation 
(molecular/cellular, physiological/whole-body, population, public health) and between 
observational and mechanistic approaches, and frequently these have not communicated with 
one another. Gaining mechanistic insight is critical, and there is much to be gained by a 
comparative approach. Indeed, advances in human nutrition will continue to be dependent on 
knowledge obtained from other species.  
Nutrition must also harness new scientific concepts and technologies as soon as they 
arise, and indeed be at the forefront of developments in the biosciences. The discipline was slow 
to embrace the genetic revolution, and the subsequent opportunities provided by ‘omics’. 
Nevertheless, they are now part of nutritional science and nutrigenomics is an established field. 
Delay in embracing new dimensions slows development and risks reducing the attractiveness of 
nutrition to talented young scientists. Finally, it is essential to follow what one believes in - and 
to be willing to challenge embedded scientific, social and cultural assumptions.  
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Legends to Figures 
 
Figure 1. Schematic representation of the cellular responses to hypoxia by human adipocytes 
(modified from24). angptl4, angiopoietin-like protein-4; FA, fatty acid; GLUT1, facilitative 
glucose transporter 1; HIF-1, hypoxia-inducible factor-1; MCT1, monocarboxylate transporter-1; 
MMP, matrix metalloproteinases; MT-3, metallothionein-3; PAI-1, plasminogen activator 
inhibitor-1; PPARγ, peroxisome proliferator-activated receptor; TF, transcription factors 
(additional to HIF-1); UCP2, uncoupling protein-2; VEGF, vascular endothelial growth factor. 
 
Figure 2. Oxygen as a forgotten nutrient. Article proposing that oxygen is a macronutrient 
which should be considered part of nutritional science.24  
 
Figure 3. Figures from Nature paper published in 1977 showing defective 
thermoregulation/thermogenesis in pre-obese ob/ob mice.1 Simplicity can be potent. 
 
 





